Why the study?
Does UD-CG 212 Cl increase myofibrillar Ca2+ sensitivity in canine ventricular myocardium?
Does UD-CG 212 Cl increase myofibrillar Ca2+ sensitivity in canine ventricular myocardium?
UD-CG 212 Cl, an active metabolite of pimobendan, exerts a positive inotropic effect partly by increasing myofibrillar Ca2+ sensitivity via a cAMP-dependent signal transduction pathway.
Answers are grounded in this paper and cite their sources.
Supports pimobendan metabolite mechanism in canine models; hypothesis-generating for human translation, no practice change.
We performed experiments in canine ventricular trabeculae loaded with aequorin to elucidate the mechanism of positive inotropic effect of UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H-benzimidazole-5-yl]-5-methyl-3(2H)-pyridazinone), an active metabolite of pimobendan. The maximum response to UD-CG 212 Cl achieved at 10(-5) M was 18% of ISOmax and it was associated with an increase in Ca2+ transients of 7% of ISOmax. For a given increase in force, the increase in Ca2+ transients induced by UD-CG 212 Cl was less than that induced by elevation of [Ca2+]o. The positive inotropic effect of UD-CG 212 Cl was not associated with an impairment of relaxation and it was abolished by carbachol. In conclusion, UD-CG 212 Cl has a positive inotropic effect partly due to an increase in myofibrillar Ca2+ sensitivity that is exerted via cross talk with a signal transduction pathway that involves cAMP.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: